Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Allendorf

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Surgery|October 8, 2024
Language-based exclusion associations with racial and ethnic disparities in thyroid cancer clinical trialsLikolani Arthurs, Samuel Fredericks, Younes Attlassy, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|September 7, 2023
A Novel Risk Score to Predict Hungry Bone Syndrome After Parathyroidectomy for Renal HyperparathyroidismSruthi Ramesh, Shivani Vekaria, Jason C Fisher, et al.
Surgery|October 18, 2024
Can large language models address unmet patient information needs and reduce provider burnout in the management of thyroid disease?Rajam Raghunathan, Anna R Jacobs, Vivek R Sant, et al.
Cancer|December 11, 2014
Neoadjuvant gemcitabine, docetaxel, and capecitabine followed by gemcitabine and capecitabine/radiation therapy and surgery in locally advanced, unresectable pancreatic adenocarcinomaWilliam H Sherman, Kyung Chu, John Chabot, et al.
Annals of Diagnostic Pathology|April 29, 2023
Improving fine needle aspiration to predict the tumor biological aggressiveness in pancreatic neuroendocrine tumors using Ki-67 proliferation index, phosphorylated histone H3 (PHH3), and BCL-2Chaohui Lisa Zhao, Bahram Dabiri, Iman Hanna, et al.
Surgery|January 7, 2026
Can virtual noncontrast computed tomography improve the diagnostic uncertainty of adrenal incidentalomas?Likolani Arthurs, Max Schumm, Paige Curcio, et al.
Surgery|December 10, 2025
Overscreening of patients on glucagon-like peptide-1 receptor agonists: A second "epidemic" of thyroid cancer overdiagnosis?Rajam Raghunathan, Anna Jacobs, Zoran Gajic, et al.
Clinical Endoscopy|July 16, 2019
The Role of Endoscopic Ultrasound-Guided Ki67 in the Management of Non-Functioning Pancreatic Neuroendocrine TumorsYongYan Cui, Lauren G Khanna, Anjali Saqi, et al.
Cancer Science|January 14, 2026
Neoadjuvant Therapy-Induced Remodeling in Pancreatic Ductal Adenocarcinoma: Multimodal Spatial Analysis and PrognosisXiaofei Zhang, Ruoxin Lan, Danting Li, et al.
Research Square|May 27, 2024
Enhanced Complement Expression in the Tumor Microenvironment Following Neoadjuvant Therapy: Implications for Immunomodulation and Survival in Pancreatic Ductal AdenocarcinomaXiaofei Zhang, Ruoxin Lan, Yongjun Liu, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Surgery|October 8, 2024
Language-based exclusion associations with racial and ethnic disparities in thyroid cancer clinical trialsLikolani Arthurs, Samuel Fredericks, Younes Attlassy, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|September 7, 2023
A Novel Risk Score to Predict Hungry Bone Syndrome After Parathyroidectomy for Renal HyperparathyroidismSruthi Ramesh, Shivani Vekaria, Jason C Fisher, et al.
Surgery|October 18, 2024
Can large language models address unmet patient information needs and reduce provider burnout in the management of thyroid disease?Rajam Raghunathan, Anna R Jacobs, Vivek R Sant, et al.
Cancer|December 11, 2014
Neoadjuvant gemcitabine, docetaxel, and capecitabine followed by gemcitabine and capecitabine/radiation therapy and surgery in locally advanced, unresectable pancreatic adenocarcinomaWilliam H Sherman, Kyung Chu, John Chabot, et al.
Annals of Diagnostic Pathology|April 29, 2023
Improving fine needle aspiration to predict the tumor biological aggressiveness in pancreatic neuroendocrine tumors using Ki-67 proliferation index, phosphorylated histone H3 (PHH3), and BCL-2Chaohui Lisa Zhao, Bahram Dabiri, Iman Hanna, et al.
Surgery|January 7, 2026
Can virtual noncontrast computed tomography improve the diagnostic uncertainty of adrenal incidentalomas?Likolani Arthurs, Max Schumm, Paige Curcio, et al.
Surgery|December 10, 2025
Overscreening of patients on glucagon-like peptide-1 receptor agonists: A second "epidemic" of thyroid cancer overdiagnosis?Rajam Raghunathan, Anna Jacobs, Zoran Gajic, et al.
Clinical Endoscopy|July 16, 2019
The Role of Endoscopic Ultrasound-Guided Ki67 in the Management of Non-Functioning Pancreatic Neuroendocrine TumorsYongYan Cui, Lauren G Khanna, Anjali Saqi, et al.
Cancer Science|January 14, 2026
Neoadjuvant Therapy-Induced Remodeling in Pancreatic Ductal Adenocarcinoma: Multimodal Spatial Analysis and PrognosisXiaofei Zhang, Ruoxin Lan, Danting Li, et al.
Research Square|May 27, 2024
Enhanced Complement Expression in the Tumor Microenvironment Following Neoadjuvant Therapy: Implications for Immunomodulation and Survival in Pancreatic Ductal AdenocarcinomaXiaofei Zhang, Ruoxin Lan, Yongjun Liu, et al.
Pageof 3